News & Press Releases
Filter by:
Michelle Capezza was quoted in a Fiduciary News article examining how decumulation strategies are reshaping fiduciary responsibilities for 401(k) plan sponsors.
Michelle Capezza was quoted in a Fiduciary News article discussing how a wave of advisor retirements increases fiduciary risk for 401(k) plan sponsors by requiring greater focus on selecting, evaluating, and monitoring successor advisors.
Sige Gutman was quoted in STAT about SCOTUS’ unanimous decision backing a generic drugmaker in a key “skinny labeling” case that is expected to support continued generic competition.
Sige Gutman was quoted in Endpoints News about SCOTUS’ unanimous decision siding with Hikma in a closely watched “skinny label” case and its implications for generic drugmakers.
‘There’s Going to Be a Learning Curve for Everyone’ – Mintz’s Gutman on Biosimilar Streamlining
June 4, 2026
Life Sciences Litigation Chair and Patent Litigation Co-chair Sige Gutman, recently spoke with Generics Bulletin about the impact of biosimilar streamlining on development, competition, and IP strategy.
Michelle Capezza was quoted in a Fiduciary News article examining what the dot-com crash can teach 401(k) fiduciaries about today’s AI-driven stock market surge.
